Carregant...
A randomized trial of teriflunomide added to glatiramer acetate in relapsing multiple sclerosis
BACKGROUND: Teriflunomide is a once-daily oral immunomodulator for the treatment of relapsing−remitting MS. OBJECTIVE: To evaluate the safety and tolerability of teriflunomide as add-on therapy to a stable dose of glatiramer acetate (GA) in patients with relapsing forms of MS (RMS). METHODS: Phase I...
Guardat en:
| Publicat a: | Mult Scler J Exp Transl Clin |
|---|---|
| Autors principals: | , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SAGE Publications
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5433345/ https://ncbi.nlm.nih.gov/pubmed/28607708 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2055217315618687 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|